Rising Blood Sugar Levels in an Adult Onset Diabetic

By Dr. Fred Raleigh
Plus Magazine


Question.

I seem to have a dilemma with rising levels of my blood sugar; perhaps you can shed some light?

Several years (4) ago I was diagnosed as having Type II Adult Onset Non-Insulin Dependent Diabetes. My physician started me on a product called Amaryl and told me to return to the office in one month. A month later when I returned to the office everything was fine. My blood sugar was in a range that my doctor liked so I was told to return just twice a year.

However, after a year had passed my blood sugar levels were found to be abnormal again. Now my doctor ordered a second agent, metformin or Glucophage - 500mg twice daily. At this time my doctor also advised me about a medical device that would allow me to monitor my blood sugar at home - Lifescan. Six months later my blood sugar was still not controlled so the doctor stopped the Glucophage and started Avandia. I continued to monitor my blood sugar but for some reason the levels remained high and were not to my doctor's liking. So my doctor now ordered a long acting insulin to be used daily and regular insulin for those times when my blood sugar reached certain predetermined levels. He called this a sliding scale for using the regular insulin. He did not discontinue the Amaryl or the Avandia. Incidentally, I walk daily and work out with weights every other day.

Regardless of the intervention employed to date, my fasting blood sugar has not been be below 160 for some time. In fact the average daily fasting blood sugar level seems to be steadily rising over these last 3 years. Occasionally when I have had to use the sliding scale with the regular insulin my blood sugar has dropped severely into the low 50's and even 40's on one occasion.

What is going on?

DW Solvang

Answer.

Life is so complex and so is the management of diabetes; whether or not you have the non-insulin dependent type or the insulin dependent kind. As our knowledge grows so does our understanding.

We now know that using members from the family of second generation sulfonylureas, like Amaryl, by themselves to treat non-insulin dependent Type II diabetes may not good in the long run. Basically these agents stimulate the pancreas to release insulin. Unfortunately over the long haul and in susceptible people, this almost constant stimulation of the pancreas by these agents can literally wear out the pancreas and generally leads to insulin dependency. Additionally, it appears that the dose of these products may have to be continuously increased to produce the desired results. Sometimes the dose of these products cannot be increased owing to intervening side effects.

Avandia, a member of the family of medications called "glitazones." These products are designed to increase the sensitivity of your body's muscle and liver cells to circulating insulin or reduce the resistance of the body's muscles and liver to circulating insulin. Thus, what insulin is present in your body will work more efficiently. Generally speaking members in this family are used in combination with either a second generation sulfonylurea like Amaryl or with metformin. At this point the story gets fuzzy.

We also have learned, in the last 3 years, that there seems to be a critical level for a two hour after meals circulating blood sugar that activates the liver to release more glucose or sugar into the blood. Below this level the liver rests and stops putting sugar into the system. One level I have read is that your circulating, two hour after meals, blood sugar levels should be below 140 particularly in the evening for your liver to rest or stop putting out glucose (sugar) into your blood. Metformin works exclusively on the liver to reduce liver or hepatic production of glucose. Metformin does not impact the pancreas like the sulfonylureas and in fasting non-diabetic individuals it does not cause hypoglycemia. There is also evidence to suggest that individuals who use metformin experience a modest 5-10% weight loss over time.

The active therapeutic dose of metformin found to be effective in most people is higher than what your doctor had prescribed for you. Evidence suggests that in many, the therapeutic dose may be closer to 1,500mg per day in divided doses. Perhaps another trial would be warranted. I would speak with my physician about this approach.

Finally, while speaking to your doctor about another possible trial with metformin you may want to speak with your doctor about why you are still receiving two oral agents and insulin as well. Perhaps it is time to consider some major changes in your therapy since you state that over the last 2-3 years your average daily fasting blood sugar is steadily rising.

Back to Articles Page